Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 2)

v3.19.3
Summary of Significant Accounting Policies (Details 2) - shares
6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Antidilutive securities 33,486,044 31,098,106
Series A Preferred Stock [Member]    
Antidilutive securities [1] 750,000 750,000
Series B Preferred Stock [Member]    
Antidilutive securities [2] 1,160,240 1,160,240
Series C Preferred Stock [Member]    
Antidilutive securities [3] 2,318,012 2,318,012
Amended and Restated 2016 (formerly 2008) Stock Incentive Plan and 2019 Omnibus Equity Incentive Plan [Member]    
Antidilutive securities 8,014,838 6,160,338
Warrant [Member]    
Antidilutive securities 21,242,954 20,709,516
[1] Assumes exchange under the terms of the October 11, 2012 Note Exchange and Purchase Agreement, as amended.
[2] Assumes exchange under the terms of the Certificate of Designation of the Relative Rights and Preferences of the Series B 10% Convertible Preferred Stock, effective May 5, 2015; excludes common shares issuable in payment of dividends on Series B Preferred upon conversion.
[3] Assumes exchange under the terms of the Certificate of Designation of the Relative Rights and Preferences of the Series C Convertible Preferred Stock, effective January 25, 2016.